|United States Of America||Issued Patent||9,622,472||04/18/2017||2011-097|
The global market for agricultural biotechnology is projected to reach $46.8B. What’s encouraging this 11% industry growth over the next 4 years are pathogens. Pathogens are very adaptive, multifaceted and rapidly acquire new traits that enable their survival. One of their most notable traits is the ability to release effector molecules and suppress plant immunity, thereby increasing disease spread and infection. Plants, too, have evolved in their defense signaling networks but it is more effective to find a preventative measure, as more energy is expended when trying to recuperate from post-infection.
UCR Researchers have identified new synthetic elicitors that are involved in the earlier stages of plant defense signaling. These compounds have a more extensive effect on plant immune responses than the existing synthetic elicitor, DCA. It has been successfully verified that the new compound exhibits higher potency in mediating disease resistance against harmful pathogens as well as enhance the plant’s inherent defense system.
synthetic elicitor, plant immune system, plant immune response, DCA, defense signaling network, transgenic plants, pathogen resistance, plant pathogen, genetically modified plant